“…The 14 included studies were conducted in the United States (Agin-Liebes et al, 2020; Nelson et al, 2019; Ross et al, 2016, 2021), Germany (Fraguell-Hernando et al, 2020; Mehnert et al, 2020), China (Li et al, 2020; Sun et al, 2021), Spain (Soto-Rubio et al, 2020), Ireland (Sarizadeh et al, 2021), Italy (Iani et al, 2020), Portugal (Juliao et al, 2017), Australia (Kissane et al, 2019), and Canada (Rodin et al, 2018). Nine studies were RCTs (Agin-Liebes et al, 2020; Iani et al, 2020; Juliao et al, 2017; Mehnert et al, 2020; Rodin et al, 2018; Ross et al, 2016, 2021; Sarizadeh et al, 2021; Soto-Rubio et al, 2020), four studies were pilot studies (Fraguell-Hernando et al, 2020; Kissane et al, 2019; Nelson et al, 2019; Sun et al, 2021), and one study was quasi-experimental study (Li et al, 2020). The sample size of each study ranged from 11 to 305 participants, with a total sample size of 1049 patients with cancer.…”